moxifloxacin
401 results
10 - 109
Moxifloxacin- FORMS
- COMMENTS
- Basis for recommendation
- References
- USUAL ADULT DOSING
- PEDIATRIC DOSING
- RENAL DOSING
- DOSING FOR GLOMERULAR FILTRATION OF 50-80
- DOSING FOR GLOMERULAR FILTRATION OF 10-50
- DOSING FOR GLOMERULAR FILTRATION OF <10 ML/MIN
- DOSING IN HEMODIALYSIS
- DOSING IN PERITONEAL DIALYSIS
- DOSING IN HEMOFILTRATION
- ADVERSE DRUG REACTIONS
- DRUG INTERACTIONS
- SPECTRUM
- RESISTANCE
- PHARMACOLOGY
Moxifloxacin- FORMS
- COMMENTS
- Basis for recommendation
- References
- USUAL ADULT DOSING
- PEDIATRIC DOSING
- RENAL DOSING
- DOSING FOR GLOMERULAR FILTRATION OF 50-80
- DOSING FOR GLOMERULAR FILTRATION OF 10-50
- DOSING FOR GLOMERULAR FILTRATION OF <10 ML/MIN
- DOSING IN HEMODIALYSIS
- DOSING IN PERITONEAL DIALYSIS
- DOSING IN HEMOFILTRATION
- ADVERSE DRUG REACTIONS
- DRUG INTERACTIONS
- SPECTRUM
- RESISTANCE
- PHARMACOLOGY
- Pneumonia, Community-Acquired (Adult)
- Pneumonia, bacterial
- Mastoiditis
- Cellulitis
- Otitis Media, Adult [acute otitis media and chronic otitis media]
Antimicrobials with Special Precautions in Diabetes- Mycobacterium fortuitum
- Sinusitis, Acute
- Bite Wounds
- Venous Cerebral Dural Sinus Thromboses
- Legionnaires' Disease
- Other atypical mycobacteria
- Mycobacterium chelonae
- Lefamulin
- Tuberculosis, Active
- Ocular Keratitis
- Bacterial Meningitis, Adult Acute Community-acquired
- Gatifloxacin
- Empyema and Parapneumonic Effusions
- Gatifloxacin
- Sepsis
- Mycobacterium spp.
- Sparfloxacin
- Ureaplasma urealyticum
- Surgical prophylaxis
- Bacteroides fragilis Group
- Anthrax, Pre-exposure and Post-Exposure Prevention
- Pretomanid
- Urethritis [Men]
- Acute Chest Syndrome/Sickle Cell Disease
- Mycoplasma hominis